Pharma stocks have lost favour amongst investors owing to the USFDA regulatory headwinds. However, this is the opportune time to buy these stocks because they have several years of strong growth in them say Rakesh Jhunjhunwala and Raamdeo Agrawal
Posts tagged Motilal Oswal
Radhakishan Damani’s Ex-Fav Small-Cap Pharma Stock Is A “High Quality Proxy Play” & Potential 100-Bagger: Experts
Leading brokerages have put the spotlight on a small-cap Pharma stock which used to be one of Radhakishan Damani’s favourite stocks. The stock has been described as a “high quality proxy play” and is already in the exalted list of potential 100-bagger stocks
Billionaires Rakesh Jhunjhunwala & MA Yusuffali Invest Big Bucks In Mid-Cap Bank Stock In Quest For Mega Gains
Billionaire stock investors are supposed to have an instinct for sniffing out undervalued stocks with the potential for hefty gains. The fact that the duo of Rakesh Jhunjhunwala & MA Yusuffali has invested large sums in a mid-cap bank implies that mega gains are in the offing for the lucky shareholders of the Bank
Porinju Veliyath & Daljeet Kohli Dissent On Fate Of Mid-Cap Pharma Stock
Daljeet Kohli is known to be a master of Pharma stocks while Porinju Veliyath is lauded for his expertise in harvesting mega gains from underdog stocks. Both have homed in on a mid-cap Pharma stock but expressed contrary views about its future prospects
Re-Rating Is Imminent For Sanjoy Bhattacharyya’s “Solitary Beacon Of Hope” Stock: Motilal Oswal
A specialty chemical stock described by Sanjoy Bhattacharyya as the “solitary beacon of hope” has caught the attention of ace stock pickers. Motilal Oswal has conducted an expert analysis and certified that re-rating is imminent for the stock and that hefty gains can be harvested from it
Mid-Cap Bank Claws Itself Back From Pariah Status And Regains Potential 100-Bagger Status
A mid-cap bank which was earlier touted as a potential “100-bagger” stock by the cognoscenti and which subsequently fell from grace owing to its “dangerous, unexpected and disappointing shift” in strategy has come back into the reckoning owing to the damage control measures implemented by its management
“100 Bagger” Pharma Stock Is At A “Game Changer” & “Strategic Inflection Point”: Motilal Oswal
A mid-cap Pharma stock projected as a potential 100-bagger by the wizards at Motilal Oswal has already filled the coffers of its shareholders with gold. It is claimed that the stock has more potential for gains because it is now at a “game changer” and “strategic inflection point”
Dolly Khanna Teams Up With Kishore Bang & Motilal Oswal To Scoop Up Micro-Cap Pharma Stock
Dolly Khanna appears to have overcome her aversion to Pharma stocks. This time, instead of being a lone wolf, she has relied on the collective wisdom of Kishore Bang and Motilal Oswal to home in on a micro-cap Pharma stock with impressive past performance and ambitious future plans
Daljeet Kohli Condemns Fav Contra Stock Of Sanjoy Bhattacharyya & Saurabh Mukherjea Even As “100 Bagger” Pharma Stock Surges
A mid-cap Pharma stock strongly recommended by Sanjoy Bhattacharyya & Saurabh Mukherjea is facing the ignominy of being declared a flop. Luckily, another “100 Bagger” Pharma stock is surging and bringing cheer to investors
Daljeet Kohli’s Fav “100-Bagger” Mid-Cap Pharma Stock Is “Ripe For Re-Rating” & Is Back In The Buy Zone
A mid-cap Pharma stock has become the favourite of several ace stock pickers because of it’s dominance in the market place, high RoEs, quality management and reasonable valuations. The stock is also proclaimed as a potential 100-bagger stock. Daljeet Kohli claims the stock is a good buy now because it is “ripe for re-rating“
Recent Comments